Cellulac formally requests Metabolix shareholders to consider merger proposal

Cellulac yesterday formally requested Metabolix shareholders to consider merger proposal. Cellulac plc is an industrial biochemicals investment technology company, that have been interested in Metabolix Inc., ($MBLX) for some time and after their announcement, in May 2016, of a strategic review, Cellulac made a formal proposal via the CEO to merge both companies.

Continue reading

Metabolix and CJ CheilJedang together for a bioplastics production unit in Iowa

fdairport1.jpgMetabolix, an U.S. advanced biomaterials company focused on sustainable solutions for the plastics industry, announced that it has entered into a Memorandum of Understanding with CJ CheilJedang Corporation (“CJ”) for a strategic commercial manufacturing arrangement for specialty PHAs, including the Company’s newly launched amorphous PHA (“a-PHA”).

CJ CheilJedang is a Korean-based food, feed, and bioscience company, and a subsidiary of the CJ Group. It is a global leader in the area of industrial biotechnology with innovations in fermentation and purification technologies.

Continue reading